Is the Measurement of Cerebral Microembolic Signals a Good Surrogate Marker for Evaluating the Efficacy of Antiplatelet Agents in the Prevention of Stroke?

By  

European Neurology, Vol. 53, Iss. 3, 2005-04 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Update on Clinical Trials of Antiplatelet Therapy for Cerebrovascular Diseases

By  

Cerebrovascular Diseases, Vol. 10, Iss. 5, 2004-11 ,pp. : 34-40

Karger

Access to resources Recommend Favorite

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 11, 2015-11 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet reactivity and nonresponse to dual antiplatelet therapy: A review

By Vila Peter M.   Zafar M. Urooj   Badimon Juan J.  

Platelets, Vol. 20, Iss. 8, 2009-08 ,pp. : 531-538

Informa Healthcare

Access to resources Recommend Favorite

Facilitating Optimal Care of Acute Coronary, Cerebrovascular and Peripheral Vascular Syndromes in the Emergency Department: The Role of Oral Antiplatelet Therapy: Special Issue on Vascular Disease: Contemporary Thoughts on the Disease and the Management Strategies (Guest Editor: Robert Harrington)

By Volturo Gregory A.   Aghababian Richard V.  

Journal of Thrombosis and Thrombolysis, Vol. 17, Iss. 1, 2004-02 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite